Hims & Hers Health continues to eye personalized services and global expansion. Read more on what investors should know about ...

These can include weight loss, loss of appetite, yellowing of the skin, vomiting or nausea, and the symptoms of diabetes ...

With the recent approval in China of Innovent Biologics' (OTCPK:IVBIY) mazdutide as the first-ever dual GLP-1/glucagon ...

These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...

The MHRA has revealed it's received more than 560 reports of acute pancreatitis in patients taking GLP-1 injections since ...